Pharmaceutical Patent Protection: the U.S. and Japan in Comparative Perspective
Osha Liang attorneys Shinya Kimura and Carlyn Burton published an article in Pharmaceutical Patent Analyst in Feb. 2017 titled “Pharmaceutical patent protection: the United States and Japan in comparative perspective.” The article discusses and compares pharmaceutical patent practices in the United States and Japan, such as patent protection of medical methods, interpretation of product-by-process claims, and patent eligibility of biotechnology inventions.
To read the article, click here (subscription required).
About Pharmaceutical Patent Analyst
Pharmaceutical Patent Analyst is a bi-monthly peer-reviewed journal from Future Science Group. The journal is an authoritative resource for researchers engaged in patent-information analysis and legal specialists working in the IP field.
